Medicine and Dentistry
Patient
100%
Age
61%
Spinal Muscular Atrophy
36%
Duchenne Muscular Dystrophy
35%
Infant
33%
Assessment
24%
Upper Limb
24%
Child
22%
Muscle
20%
Nusinersen
19%
Therapeutic Procedure
17%
Diseases
17%
Deterioration
12%
Vision
12%
Spinal Muscular Atrophy Type 2
12%
Inpatient
12%
Prematurity
11%
Kugelberg Welander Disease
11%
Gene
11%
Magnetic Resonance Imaging
10%
Follow up
10%
Werdnig Hoffmann Disease
9%
Motor Performance
9%
Phenotype
9%
Exon
9%
Neuromuscular Disease
9%
Development
8%
Diagnosis
8%
Muscular Dystrophy
8%
Combination Therapy
8%
Severe Myoclonic Epilepsy of Infancy
8%
Aptitude
7%
Brain
7%
Analysis
6%
Lesion
6%
Neurologic Examination
6%
Muscle Disorder
6%
Sleep Disorder
6%
Attention
5%
Sleep
5%
Clinical Trial
5%
Comprehension
5%
Dystrophin
5%
Psychology
Children
29%
Infant
28%
Duchenne Muscular Dystrophy
22%
Assessment
19%
Groups
14%
Spinal Muscular Atrophy
12%
Abilities
11%
Treatment
11%
Attention
10%
Cerebral Palsy
7%
Tools
7%
Preschool
6%
Sleep
5%
Biochemistry, Genetics and Molecular Biology
Nested Gene
21%
Mutation
18%
Age
17%
Genetics
11%
Phenotype
10%
SMN2
8%
Development
6%
Time
5%
